The previously announced breakthrough update to Nevisense, SciBase device for the early detection of melanoma, has now been released.

At the annual general meeting of SciBase Holding AB (publ) on 16 May 2018 in Stockholm the shareholders adopted the below resolutions.

SciBase hereby announces that the Annual report for 2017 is available at the Company’s website www.scibase.com.

The shareholders of SciBase Holding AB (publ), reg. no. 556773-4768, (hereinafter the “Company”) are hereby invited to the Annual General Meeting to be held on May 16, 2018 at 5.00 p.m. CET at Setterwalls Advokatbyrå’s  offices with address at Sturegatan 10 in Stockholm.